Open AccessHemoglobin, albumin, lymphocyte, and platelet score and neutrophil-to-lymphocyte ratio are novel significant prognostic factors for patients with small-cell lung cancer undergoing chemotherapy
Author(s) -
Ning Yang,
Xiao Han,
Jinyu Yu,
Weibin Shu,
Feng Qiu,
Jianyong Han
Publication year - 2020
Publication title -
journal of cancer research and therapeutics/journal of cancer research and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.475
H-Index - 39
eISSN - 0973-1482
pISSN - 1998-4138
DOI - 10.4103/jcrt.jcrt_1066_19
Subject(s) - medicine , hazard ratio , proportional hazards model , gastroenterology , confidence interval , chemotherapy , neutrophil to lymphocyte ratio , retrospective cohort study , oncology , lymphocyte , surgery
The hemoglobin, albumin, lymphocyte, and platelet (HALP) score, neutrophil-to-lymphocyte ratio (NLR), and platelet-to-lymphocyte ratio (PLR) are the important prognostic markers in some tumor types. This study aimed to evaluate the prognostic impact of pretreatment using HALP, NLR, and PLR for patients with small-cell lung cancer (SCLC), who were undergoing chemotherapy.